Cervical Cancer Incidence in a Prevaccine Era in the United States, 1998–2002

Saraiya, Mona; Ahmed, Faruque; Krishnan, Sheila; Richards, Thomas B.; Unger, Elizabeth R.; Lawson, Herschel W.

doi:10.1097/01.aog.0000254165.92653.e8

Cited by 114 publications

(93 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…NH black, API, AI/AN, and Hispanic women each account for a larger proportion of cervical cancer survivors than breast or colorectal cancer survivors. Higher rates of cervical cancer among non-white women are well documented and are often attributed to differences in Pap testing, including treatment of pre-invasive disease and follow-up of abnormal test results [19][20][21][22]. We also found that women diagnosed with cervical cancer have the highest risk of developing a subsequent tobacco-related malignancy over a 15-year period immediately following diagnosis, which then decreases to risks similarly observed in other cancer survivors.…”

Section: Discussionsupporting

confidence: 55%

Cervical cancer survivors at increased risk of subsequent tobacco-related malignancies, United States 1992–2008

Underwood

Rim

Fairley

et al. 2012

Cancer Causes Control

View full text Add to dashboard Cite

Purpose-Persistent smoking among cancer survivors may increase their risk of subsequent malignancies, including tobacco-related malignancies. Despite these risks, nearly 40 % of women diagnosed with cervical cancer continue to smoke after diagnosis. This study describes the relative risk of developing any subsequent and tobacco-related malignancy among cervical cancer survivors.Methods-We examined data from the year 1992 to 2008 in 13 Surveillance, Epidemiology and End Results registries. We calculated the standardized incidence ratio (SIR) and 95 % confidence limits (CLs) for all subsequent and tobacco-related malignancies among cervical cancer survivors. Tobacco-related malignancies were defined according to the 2004 Surgeon General's Report on the Health Consequences of Smoking. For comparison with cervical cancer survivors, SIRs for subsequent malignancies were also calculated for female survivors of breast or colorectal cancers.Results-The SIR of developing a subsequent tobacco-related malignancy was higher among cervical cancer survivors (SIR = 2.2, 95 % CL = 2.0-2.4). Female breast (SIR = 1.1, 95 % CL = 1.0-1.1) and colorectal cancer survivors (1.1, 1.1-1.2) also had an elevated risk. The increased risk of a subsequent tobacco-related malignancy among cervical cancer survivors was greatest in the first 5 years after the initial diagnosis and decreased as time since diagnosis elapsed.Conclusion-Women with cervical cancer have a two-fold increased risk of subsequent tobacco-related malignancies, compared with breast and colorectal cancer survivors. In an effort to decrease their risk of subsequent tobacco-related malignancies, cancer survivors should be targeted for tobacco prevention and cessation services. Special attention should be given to cervical cancer survivors whose risk is almost twice that of breast or colorectal cancer survivors.

show abstract

Section: Discussionsupporting

confidence: 55%

Cervical cancer survivors at increased risk of subsequent tobacco-related malignancies, United States 1992–2008

Underwood

Rim

Fairley

et al. 2012

Cancer Causes Control

View full text Add to dashboard Cite

show abstract

“…[14][15][16] The NBCCEDP has been able to reach populations (eg, African Americans, Hispanics, and American Indians/Alaska Natives) whose rates of screening fall far below national averages. A variety of successful recruitment strategies has made inroads in educating women about the importance of screening, explaining the services available, removing barriers to screening, and motivating women to complete screening exams as part of their routine healthcare.…”

Section: The National Breast and Cervical Cancer Early Detection Progmentioning

confidence: 99%

Preventing cervical cancer

Khan

Curtis

Ekwueme

et al. 2008

Cancer

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

“…The global annual incidence was estimated at 528,000 cases, and the annual number of CC‐related deaths was estimated at 266,000 1, 2. In the United States, CC is the third most common genital tract malignancy and approximately 12,042 new cases and 4074 deaths were attributed to this disease in 2012 2, 3. In the past 40 years, as a result of increased surveillance and improved treatment 2, 3, both the incidence and mortality of CC have significantly decreased.…”

Section: Introductionmentioning

confidence: 99%

“…In the United States, CC is the third most common genital tract malignancy and approximately 12,042 new cases and 4074 deaths were attributed to this disease in 2012 2, 3. In the past 40 years, as a result of increased surveillance and improved treatment 2, 3, both the incidence and mortality of CC have significantly decreased. Although the decline in mortality from CC has occurred across all racial and ethnic groups, a disproportionate burden of CC has been shown between African American (AA) and White women 4, 5.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

An examination of racial differences in 5‐year survival of cervical cancer among African American and white American women in the southeastern US from 1985 to 2010

et al. 2016

View full text Add to dashboard Cite

Disparities in Cervical Cancer (CC) mortality outcomes between African American (AA) and White women have been studied for decades. However, conclusions about the effect of race on CC survival differ across studies. This study assessed differences in CC survival between AA and White women diagnosed between 1985 and 2010 and treated at two major hospitals in the southeastern US. The study sample included 925 AA and 1192 White women diagnosed with cervical adenocarcinoma, adenosquamous cell carcinoma, or squamous cell carcinoma. Propensity score adjustment and matching were employed to compare 5‐year survival between the two racial groups. Crude comparisons suggested relevant racial differences in survival. However, the racial differences became of small magnitude after propensity‐score adjustment and in matched analyses. Nonlinear models identified age at diagnosis, cancer stage, mode of treatment, and histological subtype as the most salient characteristics predicting 5‐year survival of CC, yet these characteristics were also associated with race. Crude racial differences in survival might be partly explained by underlying differences in the characteristics of racial groups, such as age at diagnosis, histological subtype, cancer stage, and the mode of treatment. The study results highlight the need to improve access to early screening and treatment opportunities for AA women to improve posttreatment survival from CC.

show abstract

Cervical Cancer Incidence in a Prevaccine Era in the United States, 1998–2002

Abstract: III.

Cited by 114 publications

References 21 publications

Cervical cancer survivors at increased risk of subsequent tobacco-related malignancies, United States 1992–2008

Cervical cancer survivors at increased risk of subsequent tobacco-related malignancies, United States 1992–2008

Preventing cervical cancer

An examination of racial differences in 5‐year survival of cervical cancer among African American and white American women in the southeastern US from 1985 to 2010

Contact Info

Product

Resources

About